Healthcare
SSY Group Limited(LJUIF)
Live Price
Offline$0.4026
+0.00% today
1Y Change
-42.39%
Window
Jun 25, 2025 โ Jun 17, 2026
- Market Cap
- $6.79B
- Revenue Growth
- -27.9%
- EPS Growth
- -55.6%
- Dividend Yield
- 6.3%
Coverage: 252 bars ยท Jun 25, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SSY Group Limited (LJUIF) is a Healthcare stock with a market cap of $6.79B and listed on OTC. The stock last traded around $0.40 and down 42.4% across the available one-year price window (Jun 25, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -27.9%, EPS growth of -55.6%, a dividend yield of 6.3%. What stands out right now is revenue -27.9%, EPS -55.6%, free cash flow +706.9% with operating margin 12.1% and ROIC 3.6%. The dividend matters to the case here, with a current yield around 6.3%. Valuation is more restrained than many high-expectation growth names at P/E 14.4 and price/sales 1.6. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines LJUIF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-27.9% vs +7.6% peer median
Operating Margin
Below sector median
+12.1% vs +19.4% peer median
P/E
Below sector median
14.4 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Mar 27, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -27.9% and EPS is at -55.6%, with operating margin around 12.1%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 31, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Mar 27, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Aug 28, 2025 | โ | +0.0% | +0.0% | -6.4% |
2024 Dec 31, 2024 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Edge
LJUIF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
LJUIF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
LJUIF Max Drawdown
-42.39%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for LJUIF and SPY.
Company Overview
SSY Group Limited
Other OTC
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.
- Leadership
- Jiguang Qu
- IPO Date
- Feb 25, 2015
- Employees
- 6.1k
- Street Address
- Central Plaza
- Mailing
- Wan Chai
- Region
- Wan Chai, HK
- Reporting Currency
- USD
- Investor Line
- 852 2688 0869
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 14.4
- EV/EBITDA
- 9.5
- Price/Sales
- 1.6
- Price/Book
- 0.9
Growth
- Revenue
- -27.9%
- EPS
- -55.6%
- Free Cash Flow
- +706.9%
Profitability
- Gross Margin
- 40.4%
- Operating Margin
- 12.1%
- Net Margin
- 11.3%
- ROE
- 6.5%
- ROIC
- 3.6%
Balance Sheet
- Debt/Equity
- 0.55
- Current Ratio
- 1.89
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.